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Abstract The role of transient receptor potential vanilloid
subtype 4 (TRPV4) channels in urinary bladder afferent neural
pathways was investigated using spinal c-fos measurements in
mice. Anesthetized wild type and TRPV4 knockout (−/−)
mice underwent noxious bladder distention and treatment with
either intravesical instillation with lipopolysaccharide (LPS),
or the TRPV1 agonist resiniferatoxin (RTX), vehicle or an
intraperitoneal injected TRPV4 antagonist (HC067047).
Mice underwent paraformaldehyde perfusion for rapid fixa-
tion and L6-S1 spinal cord sections were removed followed
by immunohistochemical staining for c-fos. A number of c-fos
expressing neurons in the dorsal horns of L6-S1 spinal cord
transections were quantified. Groups were compared using
univariate ANOVA. Even with the absence of bladder inflam-
mation on H&E, the TRPV4 −/− mice still have a significant
twofold higher c-fos expression (n = 39, SD 2) after noxious
bladder distention compared to wild type mice (n = 20, SD 3).
A twofold increase in c-fos expression was observed after LPS
treatment in wild types (n = 42, SD 5), but no increase was
seen in TRPV4 −/−mice (n = 42, SD 2). After desensitization
of primary afferent C-nerve fibers with RTX, c-fos expression
in TRPV4−/−mice decreased significantly (threefold) (n = 12,
SD 4). Results imply that TRPV4 channels are important for
bladder afferent signaling. TRPV4 −/−mice bladders generate
more noxious sensory output, which is predominantly medi-
ated through TRPV1 expressing high threshold nerve fibers.
This study reveals TRPV1 related adaptive changes in afferent
pathways of the TRPV4 −/− mouse. We propose that this
effect is caused by a congenital impairment of low threshold
nerves that mediate normal bladder filling sensations.
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Introduction
Transient receptor potential vanilloid subtype 4 (TRPV4) is a
non-selective Ca2+-permeable cation channel that is located
on the membranes of urinary bladder epithelial cells [9, 14,
19, 20]. TRPV4 is part of the large family of TRP-channels
that are involved in a wide range of physiological processes
and is the most abundantly expressed TRP-channel in the
urinary bladder [8, 9, 21]. TRPV4 channels are of interest
because the channel is activated by mechanical stretch and
therefore could participate in bladder filling sensory pathways
[8, 11, 17, 24].
Under physiological conditions, stretch in the urothelium
causes a TRPV4 mediated Ca2+ influx into the cell which
triggers the release of ATP, a potent activator of afferent nerve
fibers in the bladder [8, 11, 17, 24]. These afferents contain
low and high threshold nerve fibers, that mostly consist of
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myelinated Aδ fibers, and a group of silent fibers that consist
of unmyelinated C-nerve fibers [11, 15, 17, 28]. Low thresh-
old fibers are important for normal bladder filling sensations
and respond to low bladder pressures. High threshold fibers
are only activated during high pressures (>20 cmH2O) and
silent fibers are activated during chemical irritation after
which they also become mechanosensitive. The high thresh-
old fibers express TRPV1 receptors and are important for
inflammatory responses and pain [28].
A considerable number of publications suggest that
TRPV4 channels are involved in bladder afferent pathways
[3, 10, 11, 17]. The phenotype of transgenic TRPV4 −/−mice
ismarked by an enlarged bladder capacity, diminished voiding
contractions and a reduced ATP response to urothelial stretch
[11, 17]. This body of evidence implies that TRPV4 −/−mice
have inadequate bladder filling sensations which mostly oc-
curs through low threshold afferents [28].
These characteristics make TRPV4 channels an interesting
target for pharmacological intervention for conditions like
overactive bladder syndrome (OAB) or bladder pain syn-
drome (BPS). Evidence from in vitro and in vivo experiments
confirm that the pharmacological blocking and stimulating of
TRPV4 channels can mediate a local response in the bladder
[3, 10, 25, 26]. Investigating the sensory function of TRPV4
channels higher up in the afferent neural tract could give more
insight in the function of these channels in the lower urinary
tract. To gain this insight, neural sensory information needs to
be quantified.
The spinal c-fos experimental model is an in vivomodel that
enables us to quantify afferent signaling [3, 5, 13]. After stim-
ulation, c-fos mRNA is transcribed in the nuclei of sensory
neurons [7, 18]. In mice, the afferent signals that originate in
the bladder travel via the dorsal root ganglia and enters the
spinal cord at the superficial dorsal horn area of the spinal cord
segment L6-S1 [1, 2]. Noxious stimuli in the bladder results in
the transcription of c-fos in the three main areas of the L6-S1
segment that are important in bladder afferent signaling. These
are the dorsal horns (DH) (laminea I, II, V), sacral parasympa-
thetic nuclei (SPN), and the dorsal commissure [1, 2, 13, 27].
The aim of this study was to investigate the contribution of
TRPV4 channels in bladder afferent signaling by quantifying c-
fos positive nuclei in sensory regions of the L6-S1 spinal cord
segment of normal wild type and transgenic TRPV4 −/−mice.
Materials and methods
Animal experiment
Our animal experiments were conducted with the approval of
our regional animal ethical committee Radboud University
Nijmegen Medical Centre (CDL). Wild type mice (C57BL/
6UJ) (n = 16) and TRPV4 −/− (n = 16) females of 25 g were
used for experiments. TRPV4 −/− mice (n = 16) were gener-
ously made available by Suzuki et al. [23]. Knock out of
TRPV4 in TRPV4 −/− mice was validated by Western blot-
ting and immunohistochemistry experiments [14]. The exper-
imental procedure went as followed. On day 1, mice were
anesthetized with isoflurane inhalation (1.5 %) and catheter-
ized using a thin PET tube (PE10; Intramedic Sparks, USA)
and gel lubrication. Bladders were emptied.
Four different experimental groups were created. (1) A
control group (TRPV4 −/− n = 4, wild type n = 4) received
a bladder installation of 0.1 ml of normal saline for 10min. (2)
A bladder inflammation group (TRPV4 −/− n = 4, wild type
n = 4) received an installation of 0.1 ml Lipopolysaccharide
(LPS, 5 mg/ml) (Sigma-Aldrich, St Louis, USA) in the blad-
der for 10 min. (3) A resiniferatoxin (RTX) group (TRPV4
−/− n = 4, wild type n = 4) received a bladder instillation of
0.1 ml RTX (1 nM dissolved in DMSO) (Tocris Bioscience,
Bristol, UK) for 30min to desensitize TRPV1 expressing high
threshold and silent afferent C-fibers. (4) A TRPV4 antagonist
group (TRPV4 −/− n = 4, wild type n = 4) received an instal-
lation of 0.1 ml of normal saline at day 1 followed by an
intraperitoneal (ip) injection of the TRPV4 antagonist HC
067047 (10 mg/kg) (Tocris Bioscience, Bristol, UK) 15 min
prior to the surgical intervention at day 2.
At day 2 (24 h later), mice from all groups were anesthe-
tized with urethane ip (2 g/kg). The abdomen was surgically
opened and an infusion needle was inserted in the bladder
dome. Bladder contractions and voiding was still possible.
The bladder was then continuously infused with normal saline
at 23 cmH2O (noxious distention) for 60 min (37 °C) (Fig. 1).
After this, the thorax was quickly opened. A needle was
inserted first in the portal vein and secondly through the left
cardiac ventricle, after which the blood supply was drained by
flushing the circulatory system with phosphate buffered saline
(PBS) (0.4 M pH 7.2). Immediately, after this, the mice
underwent a perfusion fixation procedure by flushing the cir-
culatory system with 4 % (v/v) paraformaldehyde in 0.1 M
PBS (pH 7.2), until paws and tail stiffened up. Mice were then
placed in flasks containing 4 % (v/v) paraformaldehyde in
0.1 M PBS (pH 7.2) and transported to the lab for tissue
preparation.
Tissue preparation
Spinal cords including dorsal roots ganglia were surgically
removed using a dissection microscope (Zeiss, Göttingen,
Germany) and microscopic surgery tweezers and cutting scis-
sors and subsequently fixated one night in 4 % (v/v) parafor-
maldehyde and 24 h in a 30 % (v/v) sucrose in 0.1 M PBS
solution. The L6-S1 spinal cord segment was isolated and
imbedded separately with Tissue-Tek® O.C.T. (Sakura
Finetek, Japan) and snap frozen in isopentane on dry ice and
stored at −80 °C. Sections (35 μm thick) were cut with a
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freezing microtome (Microm, Heidelberg, Germany) and col-
lected in free floating staining cups that were placed in 12 well
plates (Millipore Corporation, Billerica, USA) containing
0.1 M PBS solution (pH 7,3). Rat spinal cord cross sections
that had received a similar fixation protocol were used as
positive controls. Also, urinary bladders were removed and
immediately snap frozen in isopentane on dry ice and cut in
4-μm sections with a freezing microtome and placed on glass
slides (Superfrost®plus, Thermo-Scientific, Waltham, USA).
Immunohistochemistry
Bladder tissue was analyzed for signs of inflammation with
standard HE staining. Free floating immunohistochemistry
was performed for spinal cord c-fos experiments. Tissue was
rinsed with 0.1 M PBS solution containing 0.1 % (v/v) bovine
serum albumin and 0.3 % (v/v) Triton-X-100 (PBS-BT).
Tissue was incubated overnight with a c-fos (4) antibody (c-
fos (4) sc-52 rabbit-polyclonal Lot # L 1809, Santa Cruz®,
Santa Cruz, USA) dissolved in PBS-BT at room temperature.
We used 0.1 M PBS pH 7.3 for further rinsing steps. Tissue
was incubated with a donkey-a-rabbit IgG biotin conjugated
secondary antibody (Jackson Imm Research®, West Grove,
USA) in PBS-BT for 90 min, following incubation with
Vector ABC elite® (Vector, Burlingame, USA) for 90 min.
ammonium-nickel-sulfate dissolved in 50 ml 0.05 M Tris
buffered saline for 10 min, followed by a 10 min incubation
with the same DAB-nickel solution with the addition of
perhydrol (5 μl in 25 ml DAB-nickel solution). Tissue was
mounted on objects glasses coatedwith gelatin and dried over-
night at 37 °C, then dehydrated with ethanol and xylene and
mounted with Permount® (Thermo Fisher Scientific,
Waltham, USA). Sections were analyzed by using binocular
(Leica DMR®) microscope and processed with image J
1.41o® software.
Theory/calculation
Quantitative analyses were performed in triplo and blinded by
quantifying the c-fos positive nuclei in the (unilateral) dorsal
horn area of intact 35 μm-thick L6-S1 spinal cord transec-
tions. For each individual animal, multiple transections were
counted this way and the median number of c-fos positive
nuclei per L6-S1 dorsal horn/transection/per animal was cal-
culated. From these medians, the average number of c-fos
positive nuclei per L6-S1 dorsal horn/transection/per group
was calculated (this will be referred to as Bthe number of c-
Fig. 1 Applied experimental spinal c-fos in vivo mouse model for bladder
afferent signaling. Bladder distension is achieved via normal saline infusion
through a small syringe inserted into the bladder dome. LPS, RTX or
vehicle was instilled in the bladder via catherisation. Bladders were able
to empty during noxious distension (23 cmH2O). During stimulation,
afferent nerves (Aδ and C-fibers) are activated, and afferent signal travels
through the sacral nerves, cross the dorsal root ganglia (DRG) and enter the
superficial dorsal horn (SDH) areas of the L6-S1 spinal cord segment,
where nuclei of afferent nerves start producing c-fos in three main areas:
the dorsal horn (DH and SDH), sacral parasympathetic nuclei (SPN), and
the dorsal commissure (DCM). The bottom right image shows a c-fos
immunostaining of a L6-S1 spinal cord transection of a TRPV4 −/−
mouse that has underwent a bladder distention. Black dots are c-fos
expressing nuclei. VH = ventral horn
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Tissue was incubated using a DAB solution containing
10 μl DAB (Sigma-Aldrich, St Louis, USA) and 150 mg
fos + cells^). Groups were compared using univariate
ANOVA.
Results
A total of 26 out of 32 individual animals were included in the
evaluation. Two animals died prematurely (5 and 15 min be-
fore end of distention) during the experiment. In four animals,
L6-S1 segments were unfit for evaluation. This diminished
sample sizes in the RTX groups (n = 3, n = 3) and TRPV4
antagonist groups (n = 2, n = 2). The TRPV4 antagonist
groups were omitted from statistical evaluation because of
low number of animals. Univariate ANOVA showed statisti-
cal significant differences between groups (between-subject
effects).
Immunohistochemical staining for c-fos were performed
on L6-S1 spinal cord segments. Lower sacral and higher lum-
bar and thoracic spinal cord segments were also dissected and
stained and were clearly distinguishable in size and shape
from the L6-S1 spinal cord transections (Fig. 2a). IHC exper-
iments showed that only nuclei with c-fos immunoreactivity
were detectable and had a clear oval aspect. These c-fos pos-
itive nuclei of different sizes were clearly detectable in the
designated areas of the spinal cord sections (DH, SPN,
DCM) of mice and in rat spinal cord and brain transections
with hardly any background (Fig. 2, supplemental Figs. 1 and
2 ). The DAB-nickel immunostaining improved the contrast
and detection of c-fos expressing nuclei. The majority of c-fos
expressing cells in the dorsal horn region were detected in the
superficial dorsal horn area (SDH) followed by the lower
(anterior) laminae V area (Fig. 2b). The number of c-fos ex-
pressing nuclei in the L6-S1 dorsal horn were counted and
compared between groups. In some cases, there were consid-
erable variances observed in the number of c-fos expressing
nuclei even between two intact dorsal horns from the same
tissue transection. As a result, the experiment used all suitable
transections for analysis with an average of six representative
L6-S1 transections included for each individual animal.
Bladder distention
Distending the bladder with 23 cmH2O resulted in a large
difference in c-fos expression between wild type (n = 4) and
TRPV4 −/− mice (n = 4) (Fig. 3). Dorsal horn regions
contained a twofold higher number of c-fos positive nuclei
in the TRPV4 −/−mouse (39 + cells, SD 2) compared to wild
type mouse (20 + cells, SD 3) (p < 0.001) (Fig. 3). The
Fig. 2 a Displays the mouse spinal cord along with the cross sections at
different levels showing a distinct differences in size and shape for each
level. The dorsal horns (DH) of the L6-S1 segment was used for the
experiments. b Detail of c-fos expression in the dorsal horn (DH) area of
a L6-S1 spinal cord segments in wild type (upper image) and TRPV4 −/−
(lower image) mouse after bladder distension. C-fos expressing nuclei are
seen as black dots (blue arrows). After bladder stimulation, the majority of
c-fos expressing cells in the DH area were seen in the superficial dorsal
horn area (SDH). Other sensory areas like the sacral parasympathetic nuclei
(SPN) and the dorsal commissure (DCM) also showed increased numbers
of c-fos expressing nuclei. TRPV4 −/− mice had more c-fos expressing
nuclei after bladder distension compared to wild type mice
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bladders were evaluated after the experiment with a standard
H&E staining. No signs of inflammation or bladder wall dam-
age after bladder distention were observed in the TRPV4 −/−
or the wild types (Fig. 4a, b).
Bladder inflammation
Inducing bladder inflammation with LPS resulted in inflamma-
tory changes which was evaluated by bladder H&E staining,
which revealed a damaged umbrella cell layer, hemorrhage
within the bladder wall and bladder wall edema (Fig. 4c,
supplemental Fig. 3). Cystitis increased the number of c-fos
expressing cells significantly (twofold) in the wild type mice
(n = 4) (42 + cells, SD 5) compared to controls (n = 4) (20 +
cells, SD 3) (p < 0.001) (Fig. 4d). Induction of cystitis in the
TRPV4 −/− mice (n = 4) (42 + cells, SD 2), however, did not
result in any difference in c-fos expression when comparing
them to controls (n = 4) (39 + cells, SD 2) (Fig. 4d).
RTX treatment
Desensitizing the bladder afferent c-fibers with RTX, an
ultrapotent TRPV1 agonist, induced a threefold decrease of
c-fos activity in the TRPV4 −/−mice (n = 3) (12 + cells, SD 4)
compared to controls (n = 4) (39, SD 2) (p < 0.001) (Fig. 4d).
In the wild type mouse, a significant decrease in c-fos expres-
sion was also seen (n = 3) (11 + cells, SD 2) compared to the
non-treated controls (n = 4) (20 + cells SD 3) (p = 0.02)
(Fig. 4d). This difference was relatively lower compared to
the TRPV4 −/− mice.
TRPV4 antagonist HC 067047
Fall out in both TRPV4 −/− and wild types resulted in two
mice per treatment group. Outcomes of statistics in these low
numbers of specimens are therefore problematic and therefore
omitted. Results of c-fos activity within each group were very
comparable in all groups. A decrease in c-fos expression was
observed in the wild type treated group (15 + cells, SD 1)
compared to untreated wild types (20 + cells, SD 3). A rela-
tively smaller decrease was also observed in the HC067047
treated TRPV4 −/− group (32 + cells, SD 2) compared to
untreated TRPV4 −/− (39 + cells, SD 1).
Discussion
The spinal c-fos in vivo model was used to investigate the role
of TRPV4 channels in bladder afferent signaling during nox-
ious stretch and bladder inflammation. Results of this study
demonstrate that the TRPV4 −/− phenotype has disturbed sig-
naling during noxious stimulation of the bladder. Compared to
normal mice, there was a twofold higher c-fos expression in
the dorsal horns of TRPV4 −/− mice during noxious stretch.
This difference was unexpected, since we had hypothesized a
decrease of c-fos activity in the TRPV4 −/− mouse. Further
experiments were conducted to investigate this afferent sig-
naling paradox. An expected doubling of c-fos expression was
seen in normal mice during bladder inflammation. By con-
trast, no increase in c-fos expression was seen in the TRPV4
−/− mice. The high c-fos counts in the TRPV4 −/− dorsal
horns were, however, significantly reduced to low levels by
desensitizing primary afferent nerve fibers with the ultrapotent
TRPV1 agonist RTX. Our results confirm that TRPV4 is an
important mediator in bladder filling sensory pathways, but
other receptors of redundant pathways are likely implicated in
the TRPV4 −/− mice.
Treatment with the selective TRPV4 antagonist HC
067047 did show homogenous results within each group,
but there was considerable fall out of specimens in both treat-
ment groups resulting in small numbers per group (n = 2) that
were too low for representative statistical analysis. Results are
therefore only indicative for future studies. Compared to the
controls, the treated wild type group showed a decrease in c-
fos expression. This difference was relatively larger compared
to the treated TRPV4 −/− mice group. The same antagonist
was used previously in bladder in vivo cystometry experi-
ments by Gevaert et al. [11]. Their results demonstrated a
significant decrease in the frequency of bladder contractions
in the inflamed wild type mouse bladder. Although we used a
similar concentration and administrative route in our experi-
ment, we used the TRPV4 −/− antagonist in non-inflamed
mouse bladders. The results from this latter study and our
own results give an indication that it is worthwhile to further
Fig. 3 The results of mouse spinal c-fos measurements in L6-S1 dorsal
horns after noxious bladder distention (23 cmH2O). C-fos expression was
calculated as the average number c-fos expressing cells (nuclei) per L6-S1
dorsal horn/35 μm transection/group. Graph shows that after bladder
distention, there was a significant (*) (p < 0.001) twofold higher c-fos
expression in the L6-S1 dorsal horns of TRPV4 −/− mouse (39 + cells,
SD 2) compared to wild type mouse (20 + cells, SD 3) (p < 0.001)
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investigate the effects of HC 067047 and other TRPV4 antag-
onists on bladder afferent signaling pathways.
Spinal c-fos measurement is an established experimental
in vivo model for quantifying afferent neural signaling [5]. C-
fos is a proto-oncogene that regulates cell differentiation and
proliferation [4, 5, 13]. Quantifying afferent neural signals is
difficult. The amount of c-fos positive nuclei in designated
areas of the spinal cord highly corresponds to the intensity of
the nociceptive afferent stimulus and can therefore be used for
comparative quantitative analysis [1, 7, 13]. This model has
been used for mapping neural pathways and to evaluate the
effects of different noxious stimuli and pharmacological inter-
vention on bladder sensory pathways [1, 2, 7]. The only alter-
native model is electrophysiological recording. There are some
differences between these two models. Electrophysiological
recordings measure a more direct and continuous afferent sig-
nal, while the spinal c-fos model traps a moment in time.
Upside of this is that c-fos stains nuclei in specific anatomic
areas of the dorsal horns that are very suited for neural map-
ping, quantification and statistical analysis [13]. Other areas
with increased c-fos expression like the sacral parasympathetic
nucleus and the dorsal commissure were also detected in our
experiments. These areas were not used in our evaluation be-
cause isolating these two areas anatomically is more arbitrary
compared to the dorsal horn.
A drawback of the c-fos model is the relatively high thresh-
old for detection, since it requires a noxious stimulus for a
prolonged time to achieve high enough c-fos concentrations
for detection on immunohistochemistry [13]. A stimulus of
just over 20cmH2O during 1 h was chosen for two reasons.
The first is the requirement of a noxious, but non-traumatic
stimulus for spinal c-fos expression. The second was because
other groups have demonstrated that a stimulation durance of
1–2 h gives the highest number of c-fos expressing nuclei [1].
Urethane anesthesia was chosen because unlike other forms of
anesthesia it does not alter spinal c-fos expression [1]. Both
Fig. 4 Results of the resiniferatoxin (RTX) and lipopolysaccharide (LPS)
experiments. Images a and b show typical HE staining of WT mouse (a)
and TRPV4 −/− (b) after bladder distention (23 cmH2O). Image c shows
a WT mouse bladder after LPS treatment + distention. No signs of
bladder wall damage or inflammation characteristics were observed in
the TRPV4 −/− mice and the WT mice after distention. The LPS
treated bladders did show histochemical inflammation characteristics
with a disrupted urothelial layer (orange arrow), hemorrhage (blue
arrow), and submucosal edema (green arrow) (c). Graph d shows
results of the spinal c-fos quantification from LPS and RTX experiments.
TRPV4 −/− and wild type mice received a combination of bladder
distention (23 cmH2O) + LPS instillation (bladder inflammation)
(WT n = 4, TRPV4−/− n = 4) or a distention (23 cmH2O) + RTX
instillation (desensitizes primary afferent C-fibers) (WT n = 3, TRPV4
−/− n = 3). Treatment groups were compared to bladder distention alone
( = baseline). C-fos expression was calculated as the average number of
c-fos expressing cells (nuclei) per L6-S1 dorsal horn/35 μm transection/
group. Results are displayed as percent increase or decrease compared to
baseline and upper and lower limits display the variation within each
group. After LPS treatment, there is a significant (*) 120 % increase in
c-fos expression in the wild type mice (42 + cells, SD 5) (p < 0.001). By
contrast, only a non-significant 17% increase was seen in the TRPV4 −/−
mice after LPS treatment (42 + cells, SD 2). After RTX treatment, c-fos
expression was significantly (*) reduced in both wild type (46 %,
11 + cells, SD 2) (p = 0.02), and even more profound in TRPV4 −/−mice
(69 %, 12 + cells, SD 4) (p < 0.001) compared to controls
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the c-fos model and electrophysiological recordings have
great additional value in relation to organ confined measure-
ments like bladder cystometry for understanding the complete
afferent pathway of a sensory receptor.
The spinal c-fos model has helped to understand neurologic
bladder dysfunction due to spinal cord lesions and was used to
investigate the function of sensory receptors like TRPV1 chan-
nels and P2X receptors in the urinary bladder [2, 7, 16]. TRPV1
channels are located on bladder afferents and urothelial cells
and are involved in pain and inflammatory sensory pathways.
The TRPV1 −/− mouse phenotype shows mild voiding abnor-
malities under normal conditions and shows a decreased spinal
c-fos activity during bladder distention and inflammatory con-
ditions [2, 7]. In contrast, the TRPV4 −/− mice phenotype is
characterized by an abnormal voiding behavior and a reduced
voiding contraction frequency under normal conditions [11].
This suggests that TRPV4 channels are important for normal
bladder filling sensations that are largely dependent on low
threshold (Aδ) nerve fibers [28]. We expected lower c-fos ac-
tivity during bladder distention in these knockout mice. Results
of this study revealed the opposite meaning that the number c-
fos expressing nuclei was equivalent to cystitis conditions in
the wild type mouse. During the bladder distention in our
experiments, mice were still able to void. As a result, the
TRPV4 −/− mice may have received more noxious input dur-
ing the experiments then the wild type mice, because their
bladders maybe responded less to filling and had delayed
voiding reflexes and therefore received prolonged periods of
bladder wall stretch. This would give some explanation for
higher c-fos activity in the knockout. However, it is unlikely
that this would fully explain for the very large difference in c-
fos expression which were observed in this study. The TRPV4
−/− also responded different to the manipulation of noxious c-
fibers compared to the wild types. The LPS experiments dem-
onstrated that bladder inflammation did not cause an expected
further rise in c-fos activity in the knockout mice and the RTX
instillations decreased the high baseline c-fos expression to a
degree that was comparable wild type animals. This relative
reduction in c-fos activity was far greater in the TRPV4 −/−
mice. RTX is a super analog of capsaicin and targets and inca-
pacitates specifically the TRPV1 expressing noxious c-fibers
and does not affect the low threshold Aδ fibers that are respon-
sible for normal bladder filling sensations [8]. Although the
experiments cannot differentiate if the remaining c-fos expres-
sion after the RTX treatment originates from residual c-fiber
signaling or from Aδ signaling. By evaluating the results from
Fig. 5 Describing the proposed dysfunctional bladder afferent signaling
in the TRPV4 −/− mice. Upper figure shows normal afferent signaling
during noxious bladder distention in the wild type mouse and the
resulting c-fos expression in the sensory regions: dorsal horns (DH;
including superficial dorsal horn (SDH) areas), sacral parasympathetic
nuclei (SPN), and the dorsal commissure (DCM). Both normal low
threshold Aδ (normal bladder filling sensation) and high threshold
(noxious) C-fiber afferent nerves are activated during bladder distension
giving a mixed afferent signal through the sacral nerves into the sensory
areas of the L6-S1 spinal region. C-fos is activated only through noxious
stimuli from high threshold nerve fibers, leading to a normal rise in c-fos
expression. The lower figure displays the proposed altered bladder
afferent signaling in the TRPV4 −/− mice. Based on our results, we
suggest that normal low threshold Aδ nerve signaling for normal
bladder mechanoreception (filling sensation) is (partly) impaired and
results in a compensatory stronger afferent signal through high threshold
noxious C-nerve fibers. As a result, more c-fos (twofold) is expressed in
the designated sensory areas of the L6-S1 spinal segment
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the RTX and LPS experiments, we can still discriminate that
bladder filling signaling in the TRPV4 −/− mouse is different
compared to wild types and is primarily mediated through the
noxious, high threshold nerve fibers that express TRPV1
receptors.
The TRPV4 −/− mouse phenotype is remarkable in that it
has severe bladder dysfunction with increased micturition in-
tervals, soiling, but normal voiding contractions [11]. TRPV4
channels are located on urothelial cells and upon activation by
mechanical stretch trigger the urothelial ATP signaling path-
way [24]. Activation of urothelial TRPV4 channels by me-
chanical stretch most likely occurs through an interaction be-
tween TRPV4 channels and a network with the actin cytoskel-
eton and adherence junctions [12, 14, 22].
To date, four different types of afferent nerve fibers
that are involved in bladder mechanosensation have
been identified. Some of these are located in the bladder
mucosal area and are be part of the urothelial afferent
signaling pathway [6]. The TRPV4 knockout phenotype
has an abnormal lower urinary tract function and has
altered responses to noxious stimuli in the bladder.
This is most likely caused by an adaptation to a con-
genital impairment of low threshold nerve fiber signal-
ing (Fig. 5). This has to be taken into account when
investigating the function of TRPV4 channels in knock-
out models.
Conclusions
TRPV4 channels in the bladder are involved in bladder
afferent signaling. Bladder filling signaling function in
the TRPV4 −/− mice phenotype is more dependent on
noxious, high threshold nerves that express TRPV1
receptors.
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